- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-002351-26.
Displaying page 1 of 1.
EudraCT Number: 2014-002351-26 | Sponsor Protocol Number: CA209-238 | Start Date*: 2015-03-18 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy with Nivolumab versus Ipilimumab after Complete Resection of Stage IIIb/c or Stage IV Melanoma in Subjects who are at High Risk f... | |||||||||||||
Medical condition: High risk, completely resected Stage IIIb/c and IV melanoma subjects. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IE (Completed) GB (GB - no longer in EU/EEA) NO (Completed) FI (Completed) SE (Completed) CZ (Completed) ES (Ongoing) AT (Completed) NL (Completed) FR (Completed) HU (Completed) GR (Completed) PL (Completed) RO (Ongoing) Outside EU/EEA IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
